ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study

Wang, Dan-Dan; Zhang, Jin-Feng; Zhang, Lin-Han; Niu, Meng; Jiang, Hui-Jie*; Jia, Fu-Cang*; Feng, Shi-Ting*哈尔滨医科大学; 中国医科大学; 中山大学; 中国科学院; 1
Hepatobiliary & Pancreatic Diseases International2023-12DOI: 10.1016/j.hbpd.2022.11.005
2被引12阅读
引用收藏
分享

摘要

Background: Although transarterial chemoembolization (TACE) is the first-line therapy for intermediatestage hepatocellular carcinoma (HCC), it is not suitable for all patients. This study aimed to determine how to select patients who are not suitable for TACE as the first treatment choice. Methods: A total of 243 intermediate-stage HCC patients treated with TACE at three centers were retrospectively enrolled, of which 171 were used for model training and 72 for testing. Radiomics features were screened using the Spearman correlation analysis and the least absolute shrinkage and selection operator (LASSO) algorithm. Subsequently, a radiomics model was established using extreme gradient boosting (XGBoost) with 5-fold cross-validation. The Shapley additive explanations (SHAP) method was used to visualize the radiomics model. A clinical model was constructed using univariate and multivariate logistic regression. The combined model comprising the radiomics signature and clinical factors was then established. This model's performance was evaluated by discrimination, calibration, and clinical application. Generalization ability was evaluated by the testing cohort. Finally, the model was used to analyze overall and progression-free survival of different groups. Results: A third of the patients (81/243) were unsuitable for TACE treatment. The combined model had a high degree of accuracy as it identified TACE-unsuitable cases, at a sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of 0.759, 0.885, 0.906 [95% confidence interval (CI): 0.859-0.953] in the training cohort and 0.826, 0.776, and 0.894 (95% CI: 0.815-0.972) in the testing cohort, respectively. Conclusions: The high degree of accuracy of our clinical-radiomics model makes it clinically useful in identifying intermediate-stage HCC patients who are unsuitable for TACE treatment.

学科与关键词

关键词
Transarterial chemoembolizationHepatocellular carcinomaRadiomicsMachine learningPrediction
相关
加载中…
  • Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
    Peng, Jie*; Huang, Jinhua*; Huang, Guijia; Zhang, JingFrontiers in Oncology, 2021, 11: 730282.被引 16
  • An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma
    Zhang, Lu; Jin, Zhe; Li, Chen; He, Zicong; Zhang, Bin; Chen, Qiuying; You, Jingjing; Ma, Xiao; Shen, Hui; Wang, Fei; Wu, Lingeng*; Ma, Cunwen*; Zhang, Shuixing*Radiologia Medica, 2024.
  • Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
    Niu, Xiang-Ke; He, Xiao-Feng*WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27(2): 189-207.被引 19
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatobiliary & Pancreatic Diseases International
发表日期
2023-12
卷期
第 22 卷, 第 6 期
页码
594-604
DOI
10.1016/j.hbpd.2022.11.005
语言
ENGLISH
期刊收录
CAST-E
成果收录
SCIE
资助标注
National Key Research and Development Program [2019YFC011810 0, 2017YFC0110903]; National Natural Science Foundation of China [12026602, 81802649]; Guangdong Key Area Re-search and Development Program [2020B010165004]; Shen-zhen Key Basic Science Program [JCYJ20180507182437217]; Shenzhen Key Laboratory Program [ZDSYS201707271637577]

作者

  • W

    Wang, Dan-Dan (第一作者)

    2 · harbin med univ · chinese acad sci

  • Z

    Zhang, Jin-Feng

    harbin med univ

查看全部 7 位作者收起作者
  • Z

    Zhang, Lin-Han

    1 · harbin med univ

  • N

    Niu, Meng

    1 · china med univ

  • J

    Jiang, Hui-Jie (通讯)

    2 · harbin med univ

  • J

    Jia, Fu-Cang (通讯)

    chinese acad sci

  • F

    Feng, Shi-Ting (通讯)

    1 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417